Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer

  • Authors:
    • Gaochen Lan
    • Jie Li
    • Qiaomei Wen
    • Lin Lin
    • Libin Chen
    • Liyu Chen
    • Xi Chen
  • View Affiliations

  • Published online on: February 7, 2018     https://doi.org/10.3892/ol.2018.7991
  • Pages: 5093-5097
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cytotoxic T lymphocyte associated antigen 4 (CTLA‑4) serves an important role in inhibiting anti‑tumor immune response in the majority of solid tumors. However, a limited number of studies reported the function of CTLA‑4 in luminal B HER2‑negative breast cancer. Immunohistochemistry was performed to evaluate the expression of tumor and interstitial CTLA‑4 in luminal B HER2‑negative breast cancer tissues. The percentage of patients with tumor and interstitial CTLA‑4+ was 41.2% (42/102) and 46.1% (47/102), respectively. There was a positive association between tumor CTLA‑4 expression and interstitial CTLA‑4 expression (P<0.05). The disease‑free survival (DFS) of the tumor CTLA‑4+ group was significantly shorter compared with patients with tumor CTLA‑4‑ (mean, 89.070 vs. 39.022 months; P<0.0001). Additionally, the DFS of interstitial CTLA‑4+ group was shorter compared with the interstitial CTLA‑4‑ group (mean, 85.526 vs. 46.574 months; P<0.0001). Tumor and interstitial CTLA‑4 expression may have prognostic predicting value in luminal B HER2‑negative breast cancer. The present study may provide the basis for the use of a CTLA‑4 blocker in patients with luminal B HER2‑negative breast cancer.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lan G, Li J, Wen Q, Lin L, Chen L, Chen L and Chen X: Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer. Oncol Lett 15: 5093-5097, 2018.
APA
Lan, G., Li, J., Wen, Q., Lin, L., Chen, L., Chen, L., & Chen, X. (2018). Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer. Oncology Letters, 15, 5093-5097. https://doi.org/10.3892/ol.2018.7991
MLA
Lan, G., Li, J., Wen, Q., Lin, L., Chen, L., Chen, L., Chen, X."Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer". Oncology Letters 15.4 (2018): 5093-5097.
Chicago
Lan, G., Li, J., Wen, Q., Lin, L., Chen, L., Chen, L., Chen, X."Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer". Oncology Letters 15, no. 4 (2018): 5093-5097. https://doi.org/10.3892/ol.2018.7991